
    
      Docetaxel is being used in 60mg/m2 3 weekly dosage in Japan and several east Asian
      institutions. Docetaxel 60mg/m2 and Cisplatin 70 mg/m3 3 weekly regimen will be compared to
      Pemetrexed 500mg/m2 and Cisplatin 70 mg/m2 3 weekly regimen in first line NSCLC with
      non-squamous histology.
    
  